Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • NielQC
    Junior Member
    • Nov 2016
    • 2

    #1

    GIAB NA12878 dataset

    Hi all,
    first of all must say I'm a newbie in NGS and a completely inept in forums like this, so dont blame me too much. In fact its my first post...

    My objective is to create a pipeline for variant calling using the well known reference genome NA12878 from Genome In a Bottle (GIAB) consortium for validating my variant calls. I want to use a HiSeq 300x dataset (ftp://ftp.ncbi.nlm.nih.gov/giab/ftp/...01_HiSeq_300x/), and here my doubts started. In this directory you can see folders like that:

    - 131219_D00360_005_BH814YADXX
    - 131219_D00360_006_AH81VLADXX
    - 131223_D00360_007_BH88WKADXX
    - 131223_D00360_008_AH88U0ADXX

    ... and so on until 14 folders. I understand every folder its a run, so I went to the newest run, "131219_D00360_005_BH814YADXX", that contains 6 samples. Cant understand how and why that samples were generated. I think they were obtained from the same library (right?), so theoretically in each sample are covered the same regions. can I merge all R1 and all R2 of all samples together in an unique R1 and R2, or should I use just one sample?

    The principal problem here it's i don't understand the "sample " concept. If it's the same individual, why making 6 samples when you could just sequencing one.

    I hope I have explained clearly enough my doubts, thank you in advice

    NielQC
    Last edited by NielQC; 11-09-2016, 10:48 AM.
  • tristan dubos
    Member
    • Dec 2015
    • 39

    #2
    Hi NielQC,
    You should read ftp://ftp.ncbi.nlm.nih.gov/giab/ftp/...nd_NA12878.txt that will help you to understand
    It seems like to be a sequencing of trio then if it's not the same sample you can t merge files from different samples
    Best regards

    Comment

    • Macspider
      Member
      • Feb 2016
      • 36

      #3
      As a side note, the reason why you sequence one sample more than once is that you usually do want to have some replicates, i.e. statistical power in the subsequent analyses. This doesn't apply to every case in NGS science, but it usually does.
      For example, if you were to calculate the differentially expressed genes and had just 1 sequencing run per condition, your p-values of the differentially expressed genes would be very high. With 2 replicates per sample, they would be a bit lower and you might have some statistical confirmation that those genes are indeed differentially expressed.

      This was just an example, but the concept of replicates is very important in NGS (as it is in many science aspects), because sequencing errors happen!
      Last edited by Macspider; 11-10-2016, 02:37 AM.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 07:41 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...